|
Standard Bank Group Limited
5 September 2025
Publication of Supplementary Prospectus
The following Supplementary Prospectus has been approved by the UK Financial Conduct Authority and is available for viewing:
Supplementary Prospectus dated 5 September 2025 (the "Supplementary Prospectus") in respect of the U.S.$4,000,000,000 Euro Medium Term Note Programme of The Standard Bank of South Africa Limited and Standard Bank Group Limited.
The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 20 May 2025 relating to the above programme (the "Base Prospectus").
To view the full document, please paste the following URL into the address bar of your browser:
https://reporting.standardbank.com/debt-investors/debt-securities/
A copy of the above document has been submitted to the National Storage Mechanism: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Marc Hearn
Head of Strategic Funding
The Standard Bank of South Africa Limited
9th Floor, 5 Simmonds Street, Johannesburg, 2001
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplementary Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained therein.
In particular, the Supplementary Prospectus does not constitute an offer of securities for sale in the United States ("U.S."). The Supplementary Prospectus is not for distribution in the U.S.. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the U.S. or to, or for the account or benefit of, U.S. persons except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act. Terms used in this paragraph have the meanings given to them by Regulation S under the Securities Act.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.